TABLE 2.
Characteristics of French N. gonorrhoeae isolates associated with main NG-MAST sequence types
ST | Total no. of isolates | Isolate groupa | No. of isolates | Serotype | Geographic originb | Antibiotic susceptibility phenotypec | Antibiotic susceptibility tod: |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Penicillin | β-Lactamase | Tetracycline | Ciprofloxacin | Ceftriaxone | Spectinomycin | Erythromycin | |||||||
225 | 16 | I | 12 | B | Paris + OR | 4 | I | Negative | I or R | hR | rS | S | S |
I | 2 | B | Paris + OR | 3 | S or I | Negative | I | S | S | S | S | ||
II | 2 | B | Paris | 4 | I | Negative | R | hR | rS | S | S | ||
1479 | 9 | I | 4 | A | Paris + OR | 1 | R | Positive | hR | I or R | S | S | S |
I | 2 | A | Paris + OR | 2 | I | Negative | hR | I | S | S | S | ||
I | 2 | B | Paris + OR | 2 | I | Negative | hR | R | S | S | S | ||
II | 1 | A | Paris | 1 | R | Positive | hR | I | S | S | S | ||
880 | 4 | I | 2 | B | Paris + OR | 4 | I or R | Negative | R | hR | rS | S | S |
II | 2 | B | Paris + OR | 4 | I | Negative | R | hR | rS | S | S | ||
26 | 3 | I | 2 | B | Paris | 3 | I or S | Negative | I | S | S | S | S |
II | 1 | B | Paris | 3 | I | Negative | I | S | S | S | S | ||
437 | 3 | I | 3 | B | Paris + OR | 4 | I or R | Negative | R | R | rS | S | S |
975 | 3 | I | 3 | A | Paris + OR | 3 | S or I | Negative | S | S | S | S | S |
1986 | 3 | I | 2 | B | Paris + OR | 3 | S | Negative | S | S | S | S | S |
I | 1 | B | 4 | I | Negative | R | hR | rS | S | S | |||
2 | 2 | I | 1 | A | Paris | 3 | S | Negative | S | S | S | S | S |
I | 1 | B | OR | 3 | I | Negative | S | S | S | S | S | ||
211 | 2 | I | 2 | A | Paris + OR | 1 | R | Positive | hR | R | S | S | S |
292 | 2 | II | 1 | B | Paris | 6 | I | Negative | I | R | S | S | S |
II | 1 | B | Paris | 4 | I | Negative | R | hR | rS | S | S | ||
359 | 2 | II | 2 | B | Paris | 3 | S | Negative | I | S | S | S | S |
1813 | 2 | II | 2 | B | Paris | 3 | I | Negative | I | S | S | S | S |
1987 | 2 | I | 1 | A | Paris | 3 | S | Negative | S | S | S | S | S |
I | 1 | B | Paris | 3 | I | Negative | I | S | S | S | S |
As defined in Materials and Methods.
Paris, Paris and its surroundings; OR, other regions outside Paris and its surroundings.
As described in Table 1.
S, susceptible; I, intermediate; R, resistant; hR, high level of resistance (tetracycline MIC, ≥16 mg/liter; ciprofloxacin MIC, ≥32 mg/liter); rS, reduced susceptibility (ceftriaxone MIC, ≥0.012 and ≤0.032 mg/liter.